Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by CCPIT Patent and Trademark Law OfficeBin Zhang and Lei Fu of CCPIT Patent and Trademark Law Office consider what the Anti-Unfair Competition Law means for the Chinese IP world, and highlight influential cases showing how it protects IP rights -
Sponsored by DEQI Intellectual Property Law CorporationYuejing Li of DEQI Intellectual Property discusses the record filing system of a license for patent exploitation in China
-
Sponsored by Jadong IP Law FirmXiangjing Luo and Lian Yunze of Jadong IP Law Firm assess the key practical differences and implications that will arise from the third amendment to China’s law on copyrights
-
Sponsored by Lifang & PartnersShan Jiao of Lifang & Partners explores how standard essential patents litigation in China has evolved following recent developments in the area
-
Sponsored by Liu, Shen & AssociatesGuanyang Yao and Xiaoning Yu of Liu Shen & Associates consider the reasons behind China’s growth as a litigation venue for standard essential patent cases and evaluate the strategies of related parties
-
Sponsored by Panawell & PartnersFeng Xu of Panawell & Partners explains how the amendments to the Patent Law will impact the activity of domestic and foreign innovators
